CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 2	$ 1
Operating expenses:
Research and development	347	126
General and administrative	747	1,617
Total operating expenses	1,094	1,743
Loss from operations	(1,092)	(1,742)
Other income:
Other income, net	19	60
Other income, net	19	60
Net loss	$ (1,073)	$ (1,682)
Earnings per share, Basic	$ (0.67)	$ (1.05)
Earnings per share, Diluted	$ (0.67)	$ (1.05)
Weighted average common shares outstanding, basic	1,601,252	1,601,252
Weighted average common shares outstanding, diluted	1,601,252	1,601,252